Life's Essential 8 and healthy longevity among people with and without cardiometabolic multimorbidity: A prospective study of UK Biobank
Related Experiment Video
Updated: Jul 13, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
Published on: May 18, 2022
Miao Huang1,2, Ru Fu1, Xiexiong Zhao1
1Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Insights
Improving cardiovascular health with Life's Essential 8 (LE8) significantly lowers mortality risk and extends life expectancy, even for individuals with multiple cardiometabolic diseases (CMM). Higher LE8 scores consistently correlate with better health outcomes.
Area of Science:
- Cardiovascular Health
- Public Health
- Epidemiology
Background:
- Cardiometabolic multimorbidity (CMM) presents a significant public health challenge, associated with increased mortality and reduced life expectancy.
- Assessing cardiovascular health (CVH) through metrics like Life's Essential 8 (LE8) is crucial for understanding its impact on diverse patient groups.
Purpose of the Study:
- To investigate the independent and combined effects of Life's Essential 8 (LE8) scores on mortality risk and life expectancy.
- To analyze these impacts across different strata of cardiometabolic disease status, including no cardiometabolic diseases (CMD), single cardiometabolic disease (SCMD), and cardiometabolic multimorbidity (CMM).
Main Methods:
- Utilized data from 264,675 UK Biobank participants.
- Categorized participants into low, moderate, and high CVH levels based on LE8 scores.
- Employed Cox proportional hazards and flexible parametric survival models to assess mortality risk and estimate life expectancy.
Main Results:
- A 10-point increase in LE8 score was associated with a ~20% reduction in all-cause mortality risk across all disease groups.
- Individuals with CMM and low CVH had a 6.49-fold increased mortality risk compared to CMD-free individuals with high CVH.
- High CVH was linked to a 66.12% reduction in CMM-related mortality risk and significantly increased residual life expectancy.
Conclusions:
- Higher LE8 scores are robustly associated with decreased mortality risk and enhanced residual life expectancy, irrespective of cardiometabolic disease status.
- Improving cardiovascular health via LE8 is a viable strategy for mitigating mortality and improving longevity in the general population and those with CMM.
Aims:
To investigate the impact of Life's Essential 8 (LE8) on mortality risk and life expectancy in patients with and without cardiometabolic multimorbidity (CMM).
Methods:
264,675 participants from UK Biobank were categorized into low, moderate, and high cardiovascular health (CVH) levels based on LE8 score. Baseline disease status was categorized as no cardiometabolic diseases (CMD), single cardiometabolic disease (SCMD), or CMM. The Cox proportional hazards model was used to assess the risk of all-cause mortality, and the flexible parametric survival model was employed to estimate life expectancy.
Results:
During a median follow-up of 14.27 years, 20,335 all-cause deaths occurred. For each 10-point increase in LE8 score, the risk of all-cause mortality declined by approximately 20 % whether in groups of CMD-free, SCMD, or CMM. Compared to the CMD-free with high CVH group, the adjusted hazard ratio (HR) of all-cause mortality was 2.86 (95 % CI: 1.79-4.55) for CMM patients with high CVH, and 6.49 (95 % CI: 5.56-7.58) for CMM patients with low CVH. High CVH levels reduced CMM-related mortality risk by 66.12 %. Compared to those with low CVH, residual life expectancy at age 45 of participants with high CVH extended by 11.05 years (95 % CI: 10.97-11.14) in CMD-free group, 8.73 years (95 % CI: 8.56-8.92) in SCMD group, and 8.12 years (95 % CI: 7.59-8.64) in CMM group. Among CVH components, the tobacco/nicotine score had the greatest impact on mortality risk and life expectancy.
Conclusions:
Regardless of CMM statuses, higher LE8 scores were consistently associated with lower mortality risk and longer residual life expectancy.
More Related Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
06:35Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue
Published on: April 5, 2024
Related Concept Videos
Longitudinal Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy V: Interprofessional Care
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Development of Human Microbiota